Anteris Technologies Glob... (AVR)
Anteris Technologies Global Corp. (AVR) Stock Price, Analysis & Data
| Bid | n/a |
| Market Cap | 918.06M |
| Revenue (ttm) | 2.24M |
| Net Income (ttm) | -103.56M |
| Beta | n/a |
| EPS (ttm) | -1.95 |
| PE Ratio (ttm) | n/a |
| Forward PE | -10.64 |
| P/B (ttm) | 3.65 |
| P/S (ttm) | 408.99 |
| Earnings Date | Nov 12, 2026 |
| Ask | n/a |
| Volume | 487,098 |
| Avg. Volume (20D) | 1,272,524 |
| Open | 9.27 |
| Previous Close | 9.40 |
| Day's Range | 9.22 - 9.60 |
| 52-Week Range | 3.30 - 11.05 |
| Analyst | Strong Buy |
| Price Target | 15 (59.24%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About AVR
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification prepa...
Financial Performance
In 2023, Anteris Global's revenue was 2.73M, a decrease of -14.56% compared to the previous year's 3.2M. Earnings were -46.02M, an increase of 50.58%.
Financial StatementsAnalyst Forecast
According to 3 analyst ratings, the average rating for AVR stock is "Strong Buy". The 12-month stock price forecast is 15, which is upside of 59.24% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
